175 related articles for article (PubMed ID: 32629068)
1. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
[TBL] [Abstract][Full Text] [Related]
2. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
4. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.
Jiang YR; Zhang ZH; Liu QY; Hu SY; Chen XY; Jia XB
Int J Nanomedicine; 2013; 8():2285-93. PubMed ID: 23836971
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Solubility and Permeability of Naringenin Across Non-Everted Sacs of Rat Small Intestine by Lipid Nanocapsules.
Vakilzadeh H; Varshosaz J; Soghrati S
Recent Pat Nanotechnol; 2021; 15(1):55-69. PubMed ID: 32735533
[TBL] [Abstract][Full Text] [Related]
7. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
8. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
[TBL] [Abstract][Full Text] [Related]
9. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
[TBL] [Abstract][Full Text] [Related]
10. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
Mohsen K; Azzazy HME; Allam NK; Basalious EB
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
[TBL] [Abstract][Full Text] [Related]
11. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
12. Ethyl lauroyl arginate-based hydrophobic ion pair complex in lipid nanocapsules: A novel oral delivery approach of rosmarinic acid for enhanced permeability and bioavailability.
Gad HA; Ishak RAH; Labib RM; Kamel AO
Int J Pharm; 2023 Jan; 630():122388. PubMed ID: 36375682
[TBL] [Abstract][Full Text] [Related]
13. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
[TBL] [Abstract][Full Text] [Related]
15. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
16. Formulation of lyophilized oily-core poly-Ɛ-caprolactone nanocapsules to improve oral bioavailability of Olmesartan Medoxomil.
Khattab WM; Zein El-Dein EE; El-Gizawy SA
Drug Dev Ind Pharm; 2020 May; 46(5):795-805. PubMed ID: 32275456
[No Abstract] [Full Text] [Related]
17. Solid Lipid Nanoparticles of Dronedarone Hydrochloride for Oral Delivery: Optimization, In Vivo Pharmacokinetics and Uptake Studies.
Gambhire VM; Gambhire MS; Ranpise NS
Pharm Nanotechnol; 2019; 7(5):375-388. PubMed ID: 31376827
[TBL] [Abstract][Full Text] [Related]
18. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
Eissa MM; El-Moslemany RM; Ramadan AA; Amer EI; El-Azzouni MZ; El-Khordagui LK
PLoS One; 2015; 10(11):e0141788. PubMed ID: 26574746
[TBL] [Abstract][Full Text] [Related]
19. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
[TBL] [Abstract][Full Text] [Related]
20. Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration.
Sun R; Zhang A; Ge Y; Gou J; Yin T; He H; Wang Y; Zhang G; Kong J; Shang L; Tao X; Zhang Y; Tang X
Expert Opin Drug Deliv; 2020 Sep; 17(9):1305-1320. PubMed ID: 32538226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
